These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 26373573)

  • 1. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
    Corrales L; Gajewski TF
    Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
    Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
    Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?
    Ohkuri T; Kosaka A; Nagato T; Kobayashi H
    Hum Vaccin Immunother; 2018 Feb; 14(2):285-287. PubMed ID: 29064738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STING: a master regulator in the cancer-immunity cycle.
    Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
    Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING Signaling in Cancer Cells: Important or Not?
    Sokolowska O; Nowis D
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
    Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
    Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
    Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
    Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING pathway agonism as a cancer therapeutic.
    Flood BA; Higgs EF; Li S; Luke JJ; Gajewski TF
    Immunol Rev; 2019 Jul; 290(1):24-38. PubMed ID: 31355488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
    Chen Y; Li R; Duan Q; Wu L; Li X; Luo A; Zhang Y; Zhao N; Cui K; Wu W; Liu T; Wan JB; Deng L; Li G; Hou L; Tan W; Xiao Z
    Adv Sci (Weinh); 2024 Aug; 11(32):e2400149. PubMed ID: 38898748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.